Nu-Med Plus Inc logo

Nu-Med Plus Inc

NEW
OTCPK:NUMD (USA)  
$ 0.083 +0.0022 (+2.73%) 09:08 PM EST
At Loss
Volume:
8.76K
Avg Vol (2M):
240.25K
Trade In:
What is a stock summary page? Click here for an overview.
Volume:
8.76K
At Loss
Avg Vol (2M):
240.25K

Business Description

Description
Nu-Med Plus Inc is an medical device company principally engaged in the design, innovation, development, enhancement, and commercialization of beginning, early, and selective later-stage quality medical devices. It focuses on the formulation of Nitric Oxide powder, which is a desktop generator device which delivers inhaled Nitric Oxide to replace expensive pressurized canisters and a mobile rechargeable device to deliver inhaled Nitric Oxide gas to offer solutions to hospitals, health systems and medical community throughout the world.

Financial Strength

Name Current Vs Industry Vs History
Cash-To-Debt 0.04
Equity-to-Asset -29.29
Debt-to-Equity -0.49
Debt-to-EBITDA -0.92
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate 69.7
3-Year EPS without NRI Growth Rate 63.2
3-Year FCF Growth Rate 50

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 62.31
9-Day RSI 65.68
14-Day RSI 66.66
3-1 Month Momentum % -24.89
6-1 Month Momentum % -72.55
12-1 Month Momentum % -76.94

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 0.03
Quick Ratio 0.03
Cash Ratio 0.02

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -17.9

Profitability Rank

Name Current Vs Industry Vs History
ROA % -1064.81
ROIC % -109
3-Year ROIIC % -956.12
Years of Profitability over Past 10-Year 2

GF Value Rank

Name Current Vs Industry Vs History
EV-to-EBIT -62.59
EV-to-EBITDA -62.59
EV-to-FCF -294.44
Earnings Yield (Greenblatt) % -1.6
FCF Yield % -0.36

Financials

NUMD's 30-Y Financials
Income Statement Breakdown FY
Not Enough Data
Balance Sheet Breakdown
Not Enough Data
Cashflow Statement Breakdown
Not Enough Data

Operating Revenue by Business Segment

Operating Revenue by Geographic Region

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
Not Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:NUMD

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2025
2024
2023
2022
2021
2020
2019
2018
2017
2016

Nu-Med Plus Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.001
Beta 1.86
3-Year Sharpe Ratio 0.39
3-Year Sortino Ratio 0.9
Volatility % 704.28
14-Day RSI 66.66
14-Day ATR ($) 0.012702
20-Day SMA ($) 0.040686
12-1 Month Momentum % -76.94
52-Week Range ($) 0.0075 - 0.1355
Shares Outstanding (Mil) 83.55

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Nu-Med Plus Inc Filings

Filing Date Document Date Form
No Filing Data

Nu-Med Plus Inc Stock Events

Financials Calendars
Event Date Price ($)
No Event Data

Nu-Med Plus Inc Frequently Asked Questions

What is Nu-Med Plus Inc(NUMD)'s stock price today?
The current price of NUMD is $0.08. The 52 week high of NUMD is $0.14 and 52 week low is $0.01.
When is next earnings date of Nu-Med Plus Inc(NUMD)?
The next earnings date of Nu-Med Plus Inc(NUMD) is .
Does Nu-Med Plus Inc(NUMD) pay dividends? If so, how much?
Nu-Med Plus Inc(NUMD) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1